1196PPhase I dose escalation of MSC-1, a humanized anti-LIF monoclonal antibody, in patients (pts) with advanced solid tumours: Updated results
Borazanci, E, Schram, A, Brana, I, Villar, M Vieito, Garralda, E, Spreafico, A, Oliva, M, Lakhani, N, Wasserman, R, Hoffman, K, Hallett, R, Anido, J, Giblin, P, Pandya, N, Kelly, A, Seoane, J, Von HofVolume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz253.022
Date:
October, 2019
File:
PDF, 88 KB
2019